98 related articles for article (PubMed ID: 8066063)
1. [Increase of neopterin after treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF)].
Melichar B; Solichova D; Jebavy L
Presse Med; 1994 Mar; 23(12):581. PubMed ID: 8066063
[No Abstract] [Full Text] [Related]
2. Increased production of immune activation marker neopterin by colony-stimulating factors in gynecological cancer patients.
Marth C; Weiss G; Koza A; Reibnegger G; Daxenbichler G; Zeimet AG; Fuchs D; Wachter H; Dapunt O
Int J Cancer; 1994 Jul; 58(1):20-3. PubMed ID: 7516925
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia.
Takahashi M; Yoshida Y; Kaku K; Masaoka T; Moriyama Y; Nakanishi S; Kaneko T; Shibata A; Miwa S
Acta Haematol; 1993; 89(4):189-94. PubMed ID: 8212999
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)].
Kitamura K; Asano S; Mizoguchi H; Takaku F
Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327
[TBL] [Abstract][Full Text] [Related]
5. Clinical applications of human granulocyte-macrophage colony-stimulating factor.
Sakamoto KM; Gasson JC
Int J Cell Cloning; 1991 Nov; 9(6):531-41. PubMed ID: 1770227
[TBL] [Abstract][Full Text] [Related]
6. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R
Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076
[TBL] [Abstract][Full Text] [Related]
7. Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients.
Crispino S; Lissoni P; Ardizzoia A; Rovelli F; Perego MS; Grassi MG; Barni S; Pittalis S; Tancini G
J Biol Regul Homeost Agents; 1993; 7(3):92-4. PubMed ID: 8135145
[TBL] [Abstract][Full Text] [Related]
8. GM-CSF-mediated impairment of liver to synthesize albumin, cholinesterase, and cholesterol.
Takahashi M; Nikkuni K; Moriyama Y; Shibata A
Am J Hematol; 1991 Mar; 36(3):213-4. PubMed ID: 1996559
[TBL] [Abstract][Full Text] [Related]
9. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
[TBL] [Abstract][Full Text] [Related]
10. An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach.
Mundle S; Lefebvre P; Vekeman F; Duh MS; Rastogi R; Moyo V
Cancer; 2009 Feb; 115(4):706-15. PubMed ID: 19152429
[TBL] [Abstract][Full Text] [Related]
11. [GM-CSF and G-CSF: cytokines in clinical application].
Ruef C; Coleman DL
Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
[TBL] [Abstract][Full Text] [Related]
12. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
Aoki A; Shibata A
Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic value of interleukin-3 given alone or in combination with other cytokines.
Ganser A; Hoelzer D
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):245-6. PubMed ID: 8337137
[No Abstract] [Full Text] [Related]
14. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor.
Devereux S; Linch DC
Biotherapy; 1990; 2(4):305-13. PubMed ID: 2148492
[No Abstract] [Full Text] [Related]
16. Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Ohta M; Miura Y; Takaku F; Saito M
Exp Hematol; 1992 Oct; 20(9):1090-3. PubMed ID: 1281785
[TBL] [Abstract][Full Text] [Related]
17. [Clinical use of hematopoietic growth factors].
Robak T
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
[No Abstract] [Full Text] [Related]
18. [Clinical use of hematopoietic growth factors].
Krusius T
Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
[No Abstract] [Full Text] [Related]
19. The effect of granulocyte-macrophage colony stimulating factor on paroxysmal nocturnal hemoglobinuria: a case report.
Webb DI; Bundtzen JL
Alaska Med; 1993; 35(3):216-7, 224. PubMed ID: 8109693
[TBL] [Abstract][Full Text] [Related]
20. [Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)].
Gratwohl A; Dazzi H; Tichelli A; Stebler C; Wernli M; Thomssen C; Kim I; Dieterle A; Obrist R; Stern A
Schweiz Med Wochenschr; 1991 Mar; 121(12):413-7. PubMed ID: 2028244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
